JPRN-UMIN000002330已完成未知
Japanease multi-center clinical trial to assess the inhibitory effects of branched chain amino acids on the recurrence after curative treatment of hepatocellular carcinoma - HCC prevention study by BCAA
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Impregnated patient 2.Complication of ascites, edema and hepatic coma 3.Intrahepatic cholangiocarcinoma and metastatic liver tumor 4.Patient who is difficult to keep a diet therapy going 5.Insulin-treated diabetic patient 6.HCV negative patient after interferon therapy 7.HBsAg positive patient, heavy user of alcohol (more than 60g/day/ ethanol) 8.Patient who is in treatment with antiviral drug (Interferon, Peg-interforon, Ribavirin, etc) 9.Patient who is complicated with renal dysfunction including dialysis. 10.Patient who is associated with heavy heart, lung and hematological disorder, or others. 11.Inegible patient at a physician's discretion
研究者
相似试验
尚未招募
不适用
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
已完成
不适用
Japanese, multicenter, randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus high-flow nasal cannula oxygen therapy (HFNC) for acute hypoxemic respiratory failureacute hypoxemic respiratory failureJPRN-UMIN000028827Kobe City Medical Center General Hospital Department of Respiratory Medicine104
已完成
不适用
A multi-centre clinical trial evaluating the safety and functionality of a medical imaging device for tissue review during breast-conserving surgery.Cancer - BreastBreast CancerACTRN12623000205639OncoRes Medical Pty Ltd30
已完成
不适用
A study to evaluate the feasibility of performing genomic testing of rare cancers to match the cancer to treatment. GeNOmic MatchINg treATment fOr Rare cancers (NOMINATOR).ACTRN12616001000493Melbourne Health100
进行中（未招募）
1 期
Multicentre clinical trial to evaluate the efficacy and safety of dexketoprofen trometamol (50 mg t.i.d.) versus ketorolac (30 mg t.i.d.) and placebo by intravenous route, as part of balanced analgesic therapy with morphine, followed by an oral dosing, in the treatment of postoperative paielective orthopedic surgery (hip arthroplasty)MedDRA version: 7.0Level: PTClassification code 10020096EUCTR2004-001373-26-ESaboratorios Menarini, S.A